Press releases - 5

Domain Therapeutics appoints Sylvie Ryckebusch to board of directors

European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and inves...

Domain Therapeutics signs a multi-target research collaboration and license agreement with Boehringe...

Domain Therapeutics’ innovative business model gains validation through Prexton Therapeutics acqui...

Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor...

Domain Therapeutics and 5 SATTs announce an innovative commercial and scientific partnership to acce...

Domain Therapeutics launches dedicated bioSensAll™ website

Pfizer Inc. and Domain Therapeutics enter into a collaboration agreement on bioSensAll™

Domain Therapeutics and Merck enter into a license and collaboration agreement for development of ad...

Domain Therapeutics grants Alkermes a non-exclusive license for its G Protein-Coupled Receptor BioSe...